Baycrest is leading national efforts in early detection and early intervention in dementia, bringing research breakthroughs closer to the people who need them. Through the Centre for Aging and Brain Health Innovation (CABHI), Baycrest supports innovators developing tools that identify cognitive decline sooner and guide timely care.
​AI powered imaging technologies like BrainSee​​ are helping clinicians detect risk long before traditional methods, while advanced sensors from Xandar Kardian monitor subtle changes in vital signs that signal when early action can prevent a crisis. These advances give aging adults a better chance to stay independent and healthy, and donor support plays a vital role in moving these solutions from testing into real world use.Baycrest and CABHI have built a complete innovation ecosystem that funds discovery, validates solutions with experts and older adults, and helps healthcare organizations adopt proven technologies. This ecosystem ensures that promising ideas become practical tools for dementia care.These breakthroughs are featured in the new CABHI Impact Report, which highlights how donor investment fuels transformative innovation. Download the full report to explore how Baycrest is shaping the future of dementia prevention and brain health.

Related Articles:    News & Media, Research, Innovation

Join our email list for more Brain Matters content and news.